Stock & Company Details
GRI Bio Inc $GRI
Price:
N/A
N/A
2.2M
$4.5M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.02
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Investment Trust/Mutual Fund
GRI technical indicators
Latest GRI Bio Inc (GRI) indicator readings as of 2026-08-28.
GRI's 14-day RSI is 56.0, in neutral territory. At $1.92 it is trading 1.6% above its 200-day moving average of $1.89, and above its 50-day average of $1.70. Price sits in the middle of its Bollinger Bands ($1.36 to $2.14). ADX reads 37.2, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis.
Finance Bot
Ask your questions
Start by typing a question below.
